Read the latest positive news, breakthroughs, and inspiring stories about treatment innovation, curated daily by BrightWire.
After four decades of research, the FDA has approved tavapadon, the first entirely new class of Parkinson's medication in half a century. Patients can now take one pill daily instead of multiple doses, with fewer side effects than existing treatments.
Researchers are testing psilocybin therapy for anorexia nervosa, offering hope for patients who haven't responded to traditional treatments. Early results from a small trial show potential for this unconventional approach to help those living with one of the deadliest mental illnesses.
Scientists discovered that Parkinson's disease disrupts a newly found brain network linking thoughts to actions, not just movement. This breakthrough could lead to more effective treatments for millions.
A Case Western Reserve researcher has developed a molecule that protects brain cells from the toxic protein causing Parkinson's disease. Unlike existing treatments that only manage symptoms, this breakthrough targets the root cause.